SE463100B - 1,3-oxazolidin-2-on-derivat och foerfaranden foer framstaellning daerav - Google Patents
1,3-oxazolidin-2-on-derivat och foerfaranden foer framstaellning daeravInfo
- Publication number
- SE463100B SE463100B SE8502525A SE8502525A SE463100B SE 463100 B SE463100 B SE 463100B SE 8502525 A SE8502525 A SE 8502525A SE 8502525 A SE8502525 A SE 8502525A SE 463100 B SE463100 B SE 463100B
- Authority
- SE
- Sweden
- Prior art keywords
- compound
- oxazolidin
- phenyl
- piperidinopropyl
- following formula
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
- C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
- C07D263/08—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
- C07D263/16—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D263/18—Oxygen atoms
- C07D263/20—Oxygen atoms attached in position 2
- C07D263/22—Oxygen atoms attached in position 2 with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to other ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Neurology (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Physical Education & Sports Medicine (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP59203624A JPS6183170A (ja) | 1984-09-28 | 1984-09-28 | 新規な1,3−オキサゾリジン−2−オン誘導体およびその製造法 |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8502525D0 SE8502525D0 (sv) | 1985-05-22 |
SE8502525L SE8502525L (sv) | 1986-03-29 |
SE463100B true SE463100B (sv) | 1990-10-08 |
Family
ID=16477122
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8502525A SE463100B (sv) | 1984-09-28 | 1985-05-22 | 1,3-oxazolidin-2-on-derivat och foerfaranden foer framstaellning daerav |
Country Status (27)
Country | Link |
---|---|
US (1) | US4644063A (fr) |
JP (1) | JPS6183170A (fr) |
KR (1) | KR900004323B1 (fr) |
AR (1) | AR240924A1 (fr) |
AT (1) | AT392069B (fr) |
AU (1) | AU566419B2 (fr) |
BR (1) | BR8502707A (fr) |
CA (1) | CA1252092A (fr) |
CH (1) | CH663207A5 (fr) |
CS (1) | CS273606B2 (fr) |
DE (1) | DE3519261C2 (fr) |
DK (1) | DK165952C (fr) |
ES (2) | ES8800571A1 (fr) |
FR (1) | FR2571052B1 (fr) |
GB (2) | GB8512975D0 (fr) |
HU (1) | HU199132B (fr) |
IN (1) | IN162060B (fr) |
IT (1) | IT1208807B (fr) |
MX (2) | MX161397A (fr) |
MY (1) | MY102081A (fr) |
NL (1) | NL193191C (fr) |
NZ (1) | NZ212143A (fr) |
PH (1) | PH20852A (fr) |
RO (1) | RO91422B (fr) |
SE (1) | SE463100B (fr) |
SU (2) | SU1402263A3 (fr) |
ZA (1) | ZA854001B (fr) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6183147A (ja) * | 1984-09-28 | 1986-04-26 | Nippon Chemiphar Co Ltd | 新規なアミノアルコール誘導体およびその製造法並びにそれを有効成分とするグルタミン酸遮断剤 |
JPH0759570B2 (ja) * | 1986-05-06 | 1995-06-28 | 三井東圧化学株式会社 | 2−オキサゾリジノン類の製造方法 |
JPH0713017B2 (ja) * | 1986-06-18 | 1995-02-15 | 日本ケミファ株式会社 | 脳細胞保護作用を有する医薬組成物 |
DE3877470T2 (de) * | 1987-09-10 | 1993-06-24 | Merck Sharp & Dohme | Oxazole und thiazole zur behandlung seniler demenz. |
ATE106243T1 (de) * | 1988-03-24 | 1994-06-15 | Sankyo Co | Verwendung von isoxazolinonen als cerebro-aktive medikamente. |
JPH0314562A (ja) * | 1988-04-11 | 1991-01-23 | Nippon Chemiphar Co Ltd | 新規なアルキレンジアミン誘導体およびグルタミン酸遮断剤 |
US5187171A (en) * | 1989-01-09 | 1993-02-16 | G. D. Searle & Co. | Use of a glycine b partial agonist as an antipsychotic |
ATE170516T1 (de) * | 1992-07-14 | 1998-09-15 | Nippon Chemiphar Co | Alkylendiaminderivate |
US5698573A (en) * | 1993-09-15 | 1997-12-16 | Merck, Sharp & Dohme, Ltd. | Imidazolone and oxazolone derivatives as dopamine antagonists |
DE4425613A1 (de) * | 1994-07-20 | 1996-01-25 | Bayer Ag | 5-gliedrige Heteroaryl-oxazolidinone |
US6037354A (en) * | 1997-06-18 | 2000-03-14 | Merck & Co., Inc. | Alpha 1a adrenergic receptor antagonists |
US9717239B2 (en) | 2013-03-14 | 2017-08-01 | Akzo Nobel Chemicals International B.V. | Cellulose ether as a drift control agent and rainfastness agent |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2437389A (en) * | 1948-03-09 | Oxazoeidones and erocesstok | ||
DE1135461B (de) * | 1959-05-08 | 1962-08-30 | Knoll Ag | Verfahren zur Herstellung von basisch substituierten Phthalimidinen |
FR1301267A (fr) * | 1961-04-04 | 1962-08-17 | Science Union Et Compagnie Soc | Nouveaux dérivés de l'oxazolidinone-2 et leurs procédés de préparation |
US3131197A (en) * | 1963-03-13 | 1964-04-28 | Smith Kline French Lab | 5-(3, 4-carbonyldioxyphenyl)-3-isopropyl-2-oxazolidone |
US3576808A (en) * | 1967-09-15 | 1971-04-27 | Miles Lab | N-4-phenyl-1-piperazinylalkyl-5-phenyl-oxazolidinones |
GB1222708A (en) * | 1968-10-22 | 1971-02-17 | Delalande Sa | Novel 5-(n-substituted aminomethyl)-2-oxazolidinones and their process of preparation |
FR2179582B1 (fr) * | 1972-04-13 | 1975-10-10 | Synthelabo |
-
1984
- 1984-09-28 JP JP59203624A patent/JPS6183170A/ja active Granted
-
1985
- 1985-05-21 NZ NZ212143A patent/NZ212143A/en unknown
- 1985-05-22 GB GB858512975A patent/GB8512975D0/en active Pending
- 1985-05-22 SE SE8502525A patent/SE463100B/sv not_active IP Right Cessation
- 1985-05-23 IN IN382/MAS/85A patent/IN162060B/en unknown
- 1985-05-23 DK DK230185A patent/DK165952C/da not_active IP Right Cessation
- 1985-05-24 PH PH32310A patent/PH20852A/en unknown
- 1985-05-24 DE DE3519261A patent/DE3519261C2/de not_active Expired - Fee Related
- 1985-05-27 ES ES543517A patent/ES8800571A1/es not_active Expired
- 1985-05-27 ZA ZA854001A patent/ZA854001B/xx unknown
- 1985-05-28 CA CA000482506A patent/CA1252092A/fr not_active Expired
- 1985-05-29 KR KR1019850003726A patent/KR900004323B1/ko not_active IP Right Cessation
- 1985-05-29 US US06/739,059 patent/US4644063A/en not_active Expired - Lifetime
- 1985-05-30 RO RO118984A patent/RO91422B/ro unknown
- 1985-05-30 IT IT8567500A patent/IT1208807B/it active
- 1985-05-30 HU HU852082A patent/HU199132B/hu not_active IP Right Cessation
- 1985-05-30 GB GB08513685A patent/GB2165237B/en not_active Expired
- 1985-05-30 FR FR8508128A patent/FR2571052B1/fr not_active Expired
- 1985-05-30 SU SU853902250A patent/SU1402263A3/ru active
- 1985-05-31 MX MX205493A patent/MX161397A/es unknown
- 1985-05-31 AR AR300604A patent/AR240924A1/es active
- 1985-05-31 CS CS392785A patent/CS273606B2/cs unknown
- 1985-05-31 AT AT0165685A patent/AT392069B/de not_active IP Right Cessation
- 1985-05-31 NL NL8501579A patent/NL193191C/nl not_active IP Right Cessation
- 1985-05-31 BR BR8502707A patent/BR8502707A/pt not_active IP Right Cessation
- 1985-05-31 CH CH2317/85A patent/CH663207A5/fr not_active IP Right Cessation
- 1985-07-09 AU AU44697/85A patent/AU566419B2/en not_active Ceased
-
1986
- 1986-05-13 SU SU864027452A patent/SU1431679A3/ru active
- 1986-09-18 ES ES557075A patent/ES8802152A1/es not_active Expired
-
1987
- 1987-09-29 MY MYPI87002215A patent/MY102081A/en unknown
-
1990
- 1990-07-16 MX MX2159290A patent/MX21592A/es unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2624901B2 (ja) | ナフタレン構造を有する新しい誘導体、その製造方法及びそれを含む薬学的組成物 | |
US4876284A (en) | 1-alkyl-2-aminotetralin derivatives | |
KR890000377B1 (ko) | 아졸류의 제조방법 | |
SE463100B (sv) | 1,3-oxazolidin-2-on-derivat och foerfaranden foer framstaellning daerav | |
JPS6215546B2 (fr) | ||
DK162992B (da) | Analogifremgangsmaade til fremstilling af 1-piperazinyl-3-phenyl-indanderivater eller syreadditionssalte deraf | |
US5936091A (en) | Processes and intermediates for resolving piperidyl acetamide stereoisomers | |
CZ284256B6 (cs) | Nový způsob výroby formoterolu a příbuzných sloučenin | |
EP0030526B1 (fr) | Phényl-azacycloalcanes, procédés de préparation et préparations pharmaceutiques contenant ces composés | |
EP0413667B1 (fr) | Halogénoalkylphénolalcools, -cétones et leurs hydrates | |
EP0411912B1 (fr) | Dérivés de coumarine, leur préparation et leur utilisation pour le traitement des troubles cérébrovasculaires | |
KR910002671B1 (ko) | 아미노-알콜 유도체의 제조방법 | |
US4994617A (en) | Aminoalcohols, their preparation process and their applications, particularly in therapeutics | |
FR2479815A1 (fr) | Derives du cyclohexene | |
EP0230020B1 (fr) | 1,2,3,4,4a,9b-Hexahydro-4a-aminoalkyldibenzofurannes, procédé pour leur préparation et leur utilisation comme médicaments | |
HU185432B (en) | Process for producing indene derivatives | |
EP0724578A1 (fr) | Derives amines servant d'antagonistes des canaux a calcium | |
EP0520882B1 (fr) | Dérivés de 2-aminopyrimidine-4-carboxamide, leur préparation et leur application en thérapeutique | |
FR2702211A1 (fr) | Nouveaux dérivés de la phénoxy-2 éthylamine, leur préparation et leur application en thérapeutique. | |
CA1211441A (fr) | Procede de preparation de nouvelles piperidinoguanidines substituees, et des compositions pharmaceutiques en renfermant | |
EP0091437A1 (fr) | Derives iii de tetraline utiles therapeutiquement, procedes de preparation et preparations pharmaceutiques contenant ces composes | |
JPH0550499B2 (fr) | ||
CA2264372C (fr) | Nouveaux composes du benzocyclobutane, leur procede de preparation et les compositions pharmaceutiques qui les contiennent | |
NO160656B (no) | Fremgangsm te for fremstilling av 1-((3,4-dimetoksy)amino)-3-(m-tolyloksy)-2-propanol. | |
NO881899L (no) | Nye 2-aminoalkyl-4-benzyl-1-(2h)-ftalazino-derivater. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8502525-2 Format of ref document f/p: F |
|
NUG | Patent has lapsed |
Ref document number: 8502525-2 Format of ref document f/p: F |